Urban Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$225K Sell
9,335
-575
-6% -$15K 0.2% 97
2026
Q1
$278K Sell
9,910
-16
-0.2% -$426 0.28% 71
2025
Q4
$247K Buy
+9,926
New +$250K 0.23% 83
2020
Q4
$397K Buy
+10,784
New +$396K 0.33% 71

Other funds holding PFE

Urban Wealth Management's PFE Position: Q2 2026 in Review

Urban Wealth Management reduced its Pfizer (PFE) stake by 5.8% in Q2 2026, selling an estimated $15K and leaving 9,335 shares worth $225K. The position accounts for 0.2% of the portfolio, ranked #97.

Urban Wealth Management first reported a position in PFE in Q4 2020 and has held it in 4 quarters since. The position peaked at $397K in Q4 2020. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Urban Wealth Management held 9,335 shares of Pfizer worth $225K as of Q2 2026.
  • Urban Wealth Management sold 575 Pfizer shares in Q2 2026, an estimated $15K.
  • Pfizer made up 0.2% of Urban Wealth Management's portfolio in Q2 2026, its #97 holding.
  • Urban Wealth Management first reported a position in Pfizer in Q4 2020 and has held it in 4 quarters since.
  • Urban Wealth Management's Pfizer position peaked at $397K in Q4 2020.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Urban Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.